The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke

Catriona J Cunningham, Elena Redondo-Castro, Stuart M Allan* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) hold great potential as a regenerative therapy for stroke, leading to increased repair and functional recovery in animal models of cerebral ischaemia. While it was initially hypothesised that cell replacement was an important mechanism of action of MSCs, focus has shifted to their paracrine actions or the so called “bystander” effect. MSCs secrete a wide array of growth factors, chemokines, cytokines and extracellular vesicles, commonly referred to as the MSC secretome. There is evidence suggesting the MSC secretome can promote repair through a number of mechanisms including preventing cell apoptosis, modulating the inflammatory response and promoting endogenous repair mechanisms such as angiogenesis and neurogenesis. In this review, we will discuss the in vitro approaches currently being employed to drive the MSC secretome towards a more anti-inflammatory and regenerative phenotype. We will then examine the role of the secretome in promoting repair and improving recovery in preclinical models of cerebral ischaemia.

Original languageEnglish
Pages (from-to)1276-1292
Number of pages18
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Volume38
Issue number8
Early online date18 May 2018
DOIs
Publication statusPublished - 1 Aug 2018

Fingerprint

Mesenchymal Stromal Cells
Stroke
Brain Ischemia
Therapeutics
Bystander Effect
Neurogenesis
Chemokines
Intercellular Signaling Peptides and Proteins
Anti-Inflammatory Agents
Animal Models
Cytokines
Phenotype

Keywords

  • cell therapy
  • mesenchymal stem cell
  • repair
  • stroke
  • secretome

Cite this

The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. / Cunningham, Catriona J; Redondo-Castro, Elena; Allan, Stuart M (Corresponding Author).

In: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Vol. 38, No. 8, 01.08.2018, p. 1276-1292.

Research output: Contribution to journalArticle

@article{86d56ad9f2f544a8a83343e6f9b77de8,
title = "The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke",
abstract = "Mesenchymal stem cells (MSCs) hold great potential as a regenerative therapy for stroke, leading to increased repair and functional recovery in animal models of cerebral ischaemia. While it was initially hypothesised that cell replacement was an important mechanism of action of MSCs, focus has shifted to their paracrine actions or the so called “bystander” effect. MSCs secrete a wide array of growth factors, chemokines, cytokines and extracellular vesicles, commonly referred to as the MSC secretome. There is evidence suggesting the MSC secretome can promote repair through a number of mechanisms including preventing cell apoptosis, modulating the inflammatory response and promoting endogenous repair mechanisms such as angiogenesis and neurogenesis. In this review, we will discuss the in vitro approaches currently being employed to drive the MSC secretome towards a more anti-inflammatory and regenerative phenotype. We will then examine the role of the secretome in promoting repair and improving recovery in preclinical models of cerebral ischaemia.",
keywords = "cell therapy, mesenchymal stem cell, repair, stroke, secretome",
author = "Cunningham, {Catriona J} and Elena Redondo-Castro and Allan, {Stuart M}",
note = "The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an EPSRC and MRC Centre for Doctoral Training in Regenerative Medicine studentship grant The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an EPSRC and MRC Centre for Doctoral Training in Regenerative Medicine studentship grant EP/L014904/1.",
year = "2018",
month = "8",
day = "1",
doi = "10.1177/0271678x18776802",
language = "English",
volume = "38",
pages = "1276--1292",
journal = "Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism",
number = "8",

}

TY - JOUR

T1 - The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke

AU - Cunningham, Catriona J

AU - Redondo-Castro, Elena

AU - Allan, Stuart M

N1 - The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an EPSRC and MRC Centre for Doctoral Training in Regenerative Medicine studentship grant The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an EPSRC and MRC Centre for Doctoral Training in Regenerative Medicine studentship grant EP/L014904/1.

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Mesenchymal stem cells (MSCs) hold great potential as a regenerative therapy for stroke, leading to increased repair and functional recovery in animal models of cerebral ischaemia. While it was initially hypothesised that cell replacement was an important mechanism of action of MSCs, focus has shifted to their paracrine actions or the so called “bystander” effect. MSCs secrete a wide array of growth factors, chemokines, cytokines and extracellular vesicles, commonly referred to as the MSC secretome. There is evidence suggesting the MSC secretome can promote repair through a number of mechanisms including preventing cell apoptosis, modulating the inflammatory response and promoting endogenous repair mechanisms such as angiogenesis and neurogenesis. In this review, we will discuss the in vitro approaches currently being employed to drive the MSC secretome towards a more anti-inflammatory and regenerative phenotype. We will then examine the role of the secretome in promoting repair and improving recovery in preclinical models of cerebral ischaemia.

AB - Mesenchymal stem cells (MSCs) hold great potential as a regenerative therapy for stroke, leading to increased repair and functional recovery in animal models of cerebral ischaemia. While it was initially hypothesised that cell replacement was an important mechanism of action of MSCs, focus has shifted to their paracrine actions or the so called “bystander” effect. MSCs secrete a wide array of growth factors, chemokines, cytokines and extracellular vesicles, commonly referred to as the MSC secretome. There is evidence suggesting the MSC secretome can promote repair through a number of mechanisms including preventing cell apoptosis, modulating the inflammatory response and promoting endogenous repair mechanisms such as angiogenesis and neurogenesis. In this review, we will discuss the in vitro approaches currently being employed to drive the MSC secretome towards a more anti-inflammatory and regenerative phenotype. We will then examine the role of the secretome in promoting repair and improving recovery in preclinical models of cerebral ischaemia.

KW - cell therapy

KW - mesenchymal stem cell

KW - repair

KW - stroke

KW - secretome

UR - http://europepmc.org/abstract/med/29768965

U2 - 10.1177/0271678x18776802

DO - 10.1177/0271678x18776802

M3 - Article

C2 - 29768965

VL - 38

SP - 1276

EP - 1292

JO - Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

JF - Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

IS - 8

ER -